Pfizer developing vaccine that targets omicron; Chicago set to resume in-person classes: COVID-19 updates – USA TODAY

Share this Story

Pfizer’s CEO Albert Bourla said developing a COVID vaccine specifically designed to target omicron is “the most likely scenario.” Latest news.

Author: Celina Tebor, N’dea Yancey-Bragg

READ MORE